Hormonal
Gut microbiota dysbiosis impairs GLP-1 secretion, contributing to the progression of degenerative musculoskeletal diseases (osteoarthritis, osteoporosis, sarcopenia, and intervertebral disc degeneration).
Degenerative joint and muscle issues in aging may be linked to gut health. Restoring a healthy gut microbiome through diet (fiber/prebiotics), probiotics, or fecal microbiota transplantation (FMT) may help restore natural GLP-1 levels, potentially slowing disease progression. This is a supportive strategy, not a standalone cure.
Consequently, the gut dysbiosis associated with aging and degenerative musculoskeletal diseases impairs this metabolite-driven stimulation, resulting in GLP-1 deficiency that is not primarily regulated by diet.
Why this rating
The paper is a review article summarizing multiple preclinical and clinical studies, lacking a single primary clinical trial.
Source
Glucagon-like peptide-1: a critical link between gut microbiota dysbiosis and degenerative musculoskeletal diseases
Wenxing Yang et al. · Gut Microbes · 2026
DOI 10.1080/19490976.2026.2661854
More from this paper
- Specific gut microbial metabolites (SCFAs, Bile Acids, Tryptophan derivatives) stimulate GLP-1 secretion from intestinal L cells via specific receptors (FFAR2/3, TGR5, GPR142).Good
- GLP-1 exerts protective effects on musculoskeletal tissues (bone, cartilage, muscle, disc) by reducing inflammation, oxidative stress, and apoptosis.Moderate
Related findings · Hormonal
- Initial treatment for type 2 diabetes should be a combination of metformin and either an SGLT-2 inhibitor or a GLP-1 receptor agonist to achieve cardiorenal protection, rather than monotherapy or older agents like sulfonylureas.Strong
- For patients with specific monogenic obesity syndromes (leptin deficiency, POMC/PCSK1/LEPR mutations), targeted pharmacotherapy (recombinant leptin or setmelanotide) is highly effective and should be prioritized, unlike in polygenic obesity.Strong
- Continued weekly administration of 2.4 mg subcutaneous semaglutide prevents weight regain and promotes further weight loss in adults with overweight or obesity, whereas switching to placebo results in significant weight regain.Strong
This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →